| Literature DB >> 29128259 |
Melania H Fanok1, Amy Sun1, Laura K Fogli1, Vijay Narendran2, Miriam Eckstein3, Kasthuri Kannan4, Igor Dolgalev4, Charalampos Lazaris5, Adriana Heguy4, Mary E Laird6, Mark S Sundrud7, Cynthia Liu1, Jeff Kutok8, Rodrigo S Lacruz3, Jo-Ann Latkowski6, Iannis Aifantis5, Niels Ødum9, Kenneth B Hymes10, Swati Goel2, Sergei B Koralov11.
Abstract
Cutaneous T-cell lymphoma is a heterogeneous group of lymphomas characterized by the accumulation of malignant T cells in the skin. The molecular and cellular etiology of this malignancy remains enigmatic, and what role antigenic stimulation plays in the initiation and/or progression of the disease remains to be elucidated. Deep sequencing of the tumor genome showed a highly heterogeneous landscape of genetic perturbations, and transcriptome analysis of transformed T cells further highlighted the heterogeneity of this disease. Nonetheless, using data harvested from high-throughput transcriptional profiling allowed us to develop a reliable signature of this malignancy. Focusing on a key cytokine signaling pathway previously implicated in cutaneous T-cell lymphoma pathogenesis, JAK/STAT signaling, we used conditional gene targeting to develop a fully penetrant small animal model of this disease that recapitulates many key features of mycosis fungoides, a common variant of cutaneous T-cell lymphoma. Using this mouse model, we show that T-cell receptor engagement is critical for malignant transformation of the T lymphocytes and that progression of the disease is dependent on microbiota.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29128259 PMCID: PMC5912980 DOI: 10.1016/j.jid.2017.10.028
Source DB: PubMed Journal: J Invest Dermatol ISSN: 0022-202X Impact factor: 8.551